Related Experiment Video
Updated: Jul 17, 2025
Endaural Endoscopic Atticoantrotomy Retrograde Mastoidectomy using a Constant Suction Bone-drilling Technique
Published on: May 23, 2021
Tympanomastoidectomy versus parenteral antibiotic therapy for pediatric otorrhea
Eric Babajanian1, Christopher Nielson2, Chong Zhang3
1Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, University of Utah School of Medicine, Salt Lake City, UT, United States of America.
Insights
For pediatric chronic suppurative otitis media (CSOM) with otorrhea, tympanomastoidectomy showed faster symptom resolution than antibiotics. However, after adjusting for factors like bilateral disease, the difference was not significant. Both treatments had similar complication rates.
Area of Science:
- Otolaryngology
- Pediatric Infectious Diseases
- Surgical Efficacy
Background:
- Chronic suppurative otitis media (CSOM) with otorrhea is a common pediatric condition.
- Management often involves antibiotics or surgical intervention, but evidence comparing these for specific pediatric populations is limited.
- Otorrhea in children with CSOM without cholesteatoma requires effective treatment strategies.
Purpose of the Study:
- To compare the efficacy of tympanomastoidectomy versus parenteral antibiotic therapy for treating otorrhea in pediatric patients with CSOM.
- To evaluate the time to resolution of otorrhea and treatment-related complications for each modality.
- To identify factors influencing treatment outcomes in this patient group.
Main Methods:
- Retrospective review of 221 pediatric patients (0-18 years) treated for otorrhea at a tertiary academic pediatric hospital.
- Inclusion criteria included prior antibiotic treatment, tympanostomy tube history, otorrhea, and treatment with either tympanomastoidectomy or parenteral antibiotics.
- Time to resolution was analyzed using a Cox proportional hazard model, adjusting for age, bilateral ear disease, and comorbidities.
Main Results:
- Eighty-three ears from 58 children met the inclusion criteria.
- Tympanomastoidectomy initially showed a shorter median time to resolution (9 months) compared to parenteral antibiotics (48.5 months) (p=0.006).
- Multivariate analysis revealed bilateral ear disease status as the only independent factor associated with time to resolution (HR 0.4, p=0.03). No significant difference in complication rates was observed between the two treatments (p=0.37).
Conclusions:
- After adjusting for confounding factors, there is no significant difference in the time to resolution of otorrhea between tympanomastoidectomy and parenteral antibiotic therapy in pediatric CSOM patients.
- The decision for management should involve a thorough discussion of the risks and benefits of both surgical and antibiotic approaches.
- Bilateral ear disease status is an important consideration when predicting treatment outcomes for otorrhea in this population.
Objective:
To evaluate the efficacy of tympanomastoidectomy versus parenteral antibiotic therapy for otorrhea as a result of chronic suppurative otitis media (CSOM) without cholesteatoma in the pediatric population.
Methods:
A retrospective review of 221 patients treated for otorrhea at a tertiary academic pediatric hospital was performed to evaluate the impact of tympanomastoidectomy versus parenteral antibiotic therapy on resolution of otorrhea. Inclusion criteria were age 0-18 years, prior treatment with otic and/or oral antibiotic, prior history of tympanostomy tube placement for recurrent otitis media, history of otorrhea, treatment with tympanomastoidectomy or parenteral antibiotic therapy, and follow-up of at least 1 month after intervention. Time to resolution was compared between the two modalities adjusting for age, bilateral ear disease status, and comorbidities using a Cox proportional hazard model.
Results:
Eighty-three ears from 58 children met the inclusion criteria. Ears that initially underwent tympanomastoidectomy had a significantly shorter time to resolution of symptoms (median time to resolution) 9 months (95 % confidence interval CI: 6.2-14.8) vs. 48.5 months (95 % lower CI 9.4, p = 0.006). On multivariate analysis, however, only bilateral ear disease status was independently associated with time to resolution of symptoms (hazard ratio 0.4, 95 % CI 0.2-0.9, p = 0.03). There was no statistically significant difference in the rate of treatment-related complications when comparing tympanomastoidectomy to parenteral antibiotic therapy (p = 0.37).
Conclusion:
When adjusting for age, bilateral ear disease status, and comorbidities, there does not appear to be a significant difference in time to resolution of symptoms when comparing parenteral antibiotic therapy to tympanomastoidectomy. An informed discussion regarding risks and benefits of each approach should be employed when deciding on the next step in management for patients with CSOM who have failed more conservative therapies.
More Related Videos
09:18A Comparative Study of Drug Delivery Methods Targeted to the Mouse Inner Ear: Bullostomy Versus Transtympanic Injection
Published on: March 8, 2017
12:21The Mouse Round-window Approach for Ototoxic Agent Delivery: A Rapid and Reliable Technique for Inducing Cochlear Cell Degeneration
Published on: November 26, 2015
Related Concept Videos
01:26Tonsillitis II: Management
01:23Chronic Pharyngitis
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...